JP2008530582A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008530582A5 JP2008530582A5 JP2007556362A JP2007556362A JP2008530582A5 JP 2008530582 A5 JP2008530582 A5 JP 2008530582A5 JP 2007556362 A JP2007556362 A JP 2007556362A JP 2007556362 A JP2007556362 A JP 2007556362A JP 2008530582 A5 JP2008530582 A5 JP 2008530582A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- cyr61
- level
- antibody
- urine sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101700038590 CCN1 Proteins 0.000 claims 18
- 210000002700 Urine Anatomy 0.000 claims 11
- 201000011510 cancer Diseases 0.000 claims 10
- 102000004965 antibodies Human genes 0.000 claims 9
- 108090001123 antibodies Proteins 0.000 claims 9
- 208000009956 Adenocarcinoma Diseases 0.000 claims 1
- 206010004146 Basal cell carcinoma Diseases 0.000 claims 1
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 210000000981 Epithelium Anatomy 0.000 claims 1
- 206010017758 Gastric cancer Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000006265 Renal Cell Carcinoma Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 230000001809 detectable Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 239000007850 fluorescent dye Substances 0.000 claims 1
- 230000002496 gastric Effects 0.000 claims 1
- 201000006721 lip cancer Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 102000005614 monoclonal antibodies Human genes 0.000 claims 1
- 108010045030 monoclonal antibodies Proteins 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 238000004393 prognosis Methods 0.000 claims 1
- 230000002285 radioactive Effects 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 201000002314 small intestine cancer Diseases 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
Claims (12)
- 上皮由来の癌について患者の診断を容易化するための方法であって:
a. 該被験体から得られる試験尿サンプルに存在するCyr61のレベルを測定するステップ;
b. 該試験尿サンプルにおけるCyr61のレベルを対照尿サンプルに存在するCyr61のレベルと比較するステップ;
を含み、該対照サンプルにおけるCyr61のレベルに比べ、該試験サンプルにおけるより高いレベルのCyr61が上皮由来の癌を示す方法。 - 上皮由来の癌を有することが疑われる患者、または上皮由来の癌を有する被験体の予後診断的な評価を支援するための方法であって:
a. 第1サンプルを得るために該被験体から得られる試験尿サンプルに存在するCyr61のレベルを測定するステップ;
b. 工程(a)において決定された該Cyr61のレベルを、同じ被験体からより後の時点で得られた尿サンプルに存在するCyr61のレベルと比較するステップ;
c. 工程(b)の該比較に基づいて患者の予後を評価するステップ;
を含み、該より後の時点の該同じ患者から得られた尿サンプルにおけるより高いレベルのCyr61が癌のより攻撃的な形態への進行を示す方法。 - 前記上皮由来の癌が、乳癌、基底細胞癌、腺癌、消化管癌、口唇癌、口腔癌、食道癌、小腸癌、胃癌、結腸癌、肝癌、膀胱癌、膵臓癌、卵巣癌、子宮頸癌、肺癌、皮膚癌、前立腺癌および腎細胞癌からなる群から選択される、請求項1〜2に記載の方法。
- 前記Cyr61のレベルが、以下のステップ:
a. 前記試験サンプルまたはその調製物と、Cyr61に特異的に結合する抗体ベースの結合部分とを接触させて、抗体−Cyr61複合体を形成するステップ;および
b. 該複合体の存在を検出し、これにより、存在しているCyr61のレベルを測定するステップ;
を含む、請求項1〜2のいずれか1項に記載の方法。 - 前記抗体ベースの結合部分を、検出可能な標識で標識付けする、請求項4に記載の方法。
- 前記標識が、放射性標識、ハプテン標識、蛍光標識および酵素標識からなる群から選択される、請求項5に記載の方法。
- 前記抗体ベースの結合部分が抗体である、請求項4に記載の方法。
- 前記抗体がモノクローナル抗体である、請求項7に記載の方法。
- 尿サンプル中のCyr61を検出するためのキットであって、尿サンプルを保持するための容器、およびCyr61を特異的に結合する少なくとも一つの抗体を含むキット。
- 前記キットが、Cyr61に特異的に結合する二つの抗体を含み、一方の抗体が固相に固定化されており、他方の抗体が検出可能に標識されている、請求項9に記載のキット。
- 更に、使用説明書を含む、請求項9に記載のキット。
- 被験体の治療の指示を支援するための方法であって、該方法は、被験体から得られる尿サンプルにおけるCyr61のレベルについて試験される該被験体を得るステップを含み、ここで、臨床医が結果を精査し、もし該被験体の尿サンプルが対照尿サンプルにおけるCyr61のレベルよりもより高いCyr61のレベルを有するとき、該臨床医が、該被験体に対し、上皮由来の癌に対する治療を受けるように指示する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65411105P | 2005-02-18 | 2005-02-18 | |
US60/654,111 | 2005-02-18 | ||
PCT/US2006/005812 WO2006089212A2 (en) | 2005-02-18 | 2006-02-17 | Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008530582A JP2008530582A (ja) | 2008-08-07 |
JP2008530582A5 true JP2008530582A5 (ja) | 2009-04-16 |
JP5006802B2 JP5006802B2 (ja) | 2012-08-22 |
Family
ID=36917123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007556362A Active JP5006802B2 (ja) | 2005-02-18 | 2006-02-17 | 上皮由来の癌診断および予後診断のためのバイオマーカーとしてのCyr61 |
Country Status (7)
Country | Link |
---|---|
US (4) | US7858324B2 (ja) |
EP (1) | EP1849002A4 (ja) |
JP (1) | JP5006802B2 (ja) |
CN (1) | CN101120252A (ja) |
AU (1) | AU2006214105A1 (ja) |
CA (1) | CA2598217A1 (ja) |
WO (1) | WO2006089212A2 (ja) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
AU2006214105A1 (en) * | 2005-02-18 | 2006-08-24 | Children's Medical Center Corporation | Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
US20100137163A1 (en) | 2006-01-11 | 2010-06-03 | Link Darren R | Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors |
WO2007133710A2 (en) | 2006-05-11 | 2007-11-22 | Raindance Technologies, Inc. | Microfluidic devices and methods of use thereof |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
WO2008021123A1 (en) | 2006-08-07 | 2008-02-21 | President And Fellows Of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US8455189B2 (en) * | 2007-03-29 | 2013-06-04 | Jeffrey W. Allard | Use of HE4 for assessment of breast cancers |
WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
EP2315629B1 (en) | 2008-07-18 | 2021-12-15 | Bio-Rad Laboratories, Inc. | Droplet libraries |
HUE027332T2 (en) * | 2008-08-05 | 2016-09-28 | Toray Industries | Cancer Detection Method |
CN106039307A (zh) | 2008-08-05 | 2016-10-26 | 东丽株式会社 | 用于治疗和预防癌症的药物组合物 |
CN101747435B (zh) * | 2008-12-18 | 2013-06-19 | 上海市免疫学研究所 | 一种中和cyr61的单克隆抗体(杂交瘤)及其应用 |
EP2411148B1 (en) | 2009-03-23 | 2018-02-21 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
EP2273272A1 (en) | 2009-07-06 | 2011-01-12 | Stichting Katholieke Universiteit | Method for predicting the outcome of chemotherapy in ovarian cancer |
EP2486409A1 (en) | 2009-10-09 | 2012-08-15 | Universite De Strasbourg | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
US10837883B2 (en) | 2009-12-23 | 2020-11-17 | Bio-Rad Laboratories, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
AU2011211700B2 (en) | 2010-02-04 | 2015-06-11 | Toray Industries, Inc. | Medicament for treating and/or preventing cancer |
RU2598258C2 (ru) | 2010-02-04 | 2016-09-20 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
WO2011096528A1 (ja) | 2010-02-04 | 2011-08-11 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
DK2532366T3 (da) | 2010-02-04 | 2017-01-02 | Toray Industries | Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer |
PL2532680T3 (pl) | 2010-02-04 | 2015-10-30 | Toray Industries | Kompozycja medyczna do leczenia raka i/lub zapobiegania |
KR101805520B1 (ko) | 2010-02-04 | 2017-12-07 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US8535889B2 (en) | 2010-02-12 | 2013-09-17 | Raindance Technologies, Inc. | Digital analyte analysis |
EP3447155A1 (en) | 2010-09-30 | 2019-02-27 | Raindance Technologies, Inc. | Sandwich assays in droplets |
EP3859011A1 (en) | 2011-02-11 | 2021-08-04 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
WO2012112804A1 (en) | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
EP3216872B1 (en) | 2011-06-02 | 2020-04-01 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
AU2012271293B2 (en) * | 2011-06-16 | 2017-02-02 | Giovanni M. Pitari | Biomarkers for epithelial cancer diagnosis and treatment |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
US9181348B2 (en) | 2011-08-04 | 2015-11-10 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prophylaxis of cancer |
PL3351630T3 (pl) | 2011-08-04 | 2020-05-18 | Toray Industries, Inc. | Kompozycja farmaceutyczna zawierająca przeciwciała przeciwko CAPRIN-1 do leczenia nowotworu i/lub zapobiegania nowotworowi |
US9796775B2 (en) | 2011-08-04 | 2017-10-24 | Toray Industries, Inc. | Method for detecting pancreatic cancer |
JP6065592B2 (ja) | 2011-08-04 | 2017-01-25 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
RU2610428C2 (ru) | 2011-08-04 | 2017-02-10 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики злокачественной опухоли |
PL2740489T3 (pl) | 2011-08-04 | 2017-06-30 | Toray Industries, Inc. | Kompozycja farmaceutyczna do leczenia i/lub zapobiegania raka trzustki |
KR101968498B1 (ko) | 2011-08-04 | 2019-04-12 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
WO2013120089A1 (en) | 2012-02-10 | 2013-08-15 | Raindance Technologies, Inc. | Molecular diagnostic screening assay |
WO2013125636A1 (ja) | 2012-02-21 | 2013-08-29 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
AU2013223137B2 (en) | 2012-02-21 | 2017-10-19 | Toray Industries, Inc. | Pharmaceutical composition for treatment and/or prevention of cancer |
PT2824114T (pt) | 2012-02-21 | 2019-08-05 | Toray Industries | Composição farmacêutica para o tratamento do cancro |
IN2014KN01715A (ja) | 2012-02-21 | 2015-10-23 | Toray Industries | |
HUE036425T2 (hu) | 2012-03-30 | 2018-07-30 | Toray Industries | Gyógyászati készítmény epehólyagrák kezelésére és/vagy megelõzésére |
MX358224B (es) | 2012-03-30 | 2018-08-10 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de higado. |
WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
RU2646464C2 (ru) | 2012-07-19 | 2018-03-05 | Торэй Индастриз, Инк. | Метод детекции рака |
EP2876446B1 (en) | 2012-07-19 | 2018-12-26 | Toray Industries, Inc. | Method for detecting cancer |
EP2986762B1 (en) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
RU2678138C2 (ru) | 2013-08-09 | 2019-01-23 | Торэй Индастриз, Инк. | Фармацевтическая композиция для лечения и/или профилактики рака |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
WO2015103367A1 (en) | 2013-12-31 | 2015-07-09 | Raindance Technologies, Inc. | System and method for detection of rna species |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
CN105396136B (zh) * | 2015-11-23 | 2018-10-30 | 上海交通大学医学院附属第九人民医院 | CCN1(Cyr61)在治疗皮肤损伤及皮肤萎缩相关疾病中的应用 |
CN107422125A (zh) * | 2016-05-23 | 2017-12-01 | 中国医学科学院肿瘤医院 | 与肌层浸润性膀胱癌相关的尿液蛋白质标志物 |
EP3364190A1 (en) | 2017-02-20 | 2018-08-22 | Panka Cancer Research AG | Method of detecting cancer or cancer cells |
US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
CN108752454B (zh) * | 2018-06-19 | 2021-07-20 | 中山大学孙逸仙纪念医院 | 一种人CYR61蛋白Ser188位点磷酸化抗原、抗体及其制备方法和应用 |
CN111426835A (zh) * | 2019-01-10 | 2020-07-17 | 北京师范大学 | 肝转移癌相关的尿液蛋白标记物的筛选及其用途 |
CN112147337B (zh) * | 2020-08-19 | 2024-05-28 | 德赛诊断系统(上海)有限公司 | 一种富含半胱氨酸蛋白61高敏化学发光检测试剂盒及其制备和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9704444D0 (en) * | 1997-03-04 | 1997-04-23 | Isis Innovation | Non-invasive prenatal diagnosis |
US6355623B2 (en) * | 1998-09-24 | 2002-03-12 | Hopital-Sainte-Justine | Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage |
WO2000052204A2 (en) * | 1999-02-22 | 2000-09-08 | Orntoft Torben F | Gene expression in bladder tumors |
US20020052308A1 (en) * | 1999-03-12 | 2002-05-02 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
WO2001098359A2 (en) * | 2000-06-21 | 2001-12-27 | Wyeth | Cyr61 as a target for treatment and diagnosis of breast cancer |
WO2002026193A2 (en) * | 2000-09-29 | 2002-04-04 | Wyeth | Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
US20040086504A1 (en) * | 2001-06-21 | 2004-05-06 | Deepak Sampath | Cyr61 as a target for treatment and diagnosis of breast cancer |
US20030108963A1 (en) * | 2001-07-25 | 2003-06-12 | Millennium Pharmaceuticals, Inc. | Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer |
US20030113816A1 (en) | 2001-09-18 | 2003-06-19 | Weitz Stephen L. | Methods of assaying connective tissue growth factor |
JP2003177126A (ja) * | 2001-12-13 | 2003-06-27 | Kenichi Katsube | Ccnファミリー蛋白質活性制御剤のスクリーニング方法 |
US20040241653A1 (en) * | 2001-12-31 | 2004-12-02 | Elena Feinstein | Methods for identifying marker genes for cancer |
DK1616184T4 (en) * | 2003-03-27 | 2018-08-13 | Childrens Hospital Med Ct | Method and kit for detecting early onset of renal tubular cell damage |
JP2004315480A (ja) * | 2003-04-21 | 2004-11-11 | Yoshiyuki Kakehi | 前立腺疾患治療用医薬組成物 |
AU2006214105A1 (en) * | 2005-02-18 | 2006-08-24 | Children's Medical Center Corporation | Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin |
-
2006
- 2006-02-17 AU AU2006214105A patent/AU2006214105A1/en not_active Abandoned
- 2006-02-17 US US11/815,831 patent/US7858324B2/en active Active
- 2006-02-17 EP EP06735465A patent/EP1849002A4/en not_active Ceased
- 2006-02-17 JP JP2007556362A patent/JP5006802B2/ja active Active
- 2006-02-17 CA CA002598217A patent/CA2598217A1/en not_active Abandoned
- 2006-02-17 WO PCT/US2006/005812 patent/WO2006089212A2/en active Application Filing
- 2006-02-17 CN CNA2006800051581A patent/CN101120252A/zh active Pending
-
2010
- 2010-12-23 US US12/977,348 patent/US20110189700A1/en not_active Abandoned
-
2016
- 2016-08-29 US US15/249,829 patent/US20170205419A1/en not_active Abandoned
-
2018
- 2018-06-26 US US16/018,254 patent/US20190154693A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2008530582A5 (ja) | ||
JP2008529008A5 (ja) | ||
JP2008536098A5 (ja) | ||
Parikh et al. | Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era? | |
Best et al. | GALAD score detects early hepatocellular carcinoma in an international cohort of patients with nonalcoholic steatohepatitis | |
US10408839B2 (en) | Biomarker panel for diagnosing cancer | |
Nesterova et al. | Autoantibody biomarker opens a new gateway for cancer diagnosis | |
Myers et al. | Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study | |
Lee et al. | Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma | |
RU2014112350A (ru) | Способ детекции нуклеосом, содержащих нуклеотиды | |
Zhang et al. | Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma | |
JP2014529405A (ja) | ヒストン変種含有ヌクレオソーム検出法 | |
Bertok et al. | Advanced impedimetric biosensor configuration and assay protocol for glycoprofiling of a prostate oncomarker using Au nanoshells with a magnetic core | |
WO2020225426A1 (en) | Colorectal cancer screening examination and early detection method | |
JP6829445B2 (ja) | 肝細胞癌および膵臓がんを診断するためのラミニン2の使用 | |
Kazuno et al. | Multi-sequential surface plasmon resonance analysis of haptoglobin–lectin complex in sera of patients with malignant and benign prostate diseases | |
RU2019104870A (ru) | Комбинированный тест на наличие колоректального рака | |
ES2951136T3 (es) | Uso de complejos del factor de transcripción de ADN para la detección del cáncer | |
CN106680515B (zh) | 用于肺癌诊断的多分子标志物组合 | |
Wang et al. | MXenes-Au NPs modified electrochemical biosensor for multiple exosome surface proteins analysis | |
JP2012531612A5 (ja) | ||
JP2018136122A (ja) | 膵がんを診断するための血漿バイオマーカーパネル | |
Hsu et al. | Instrument-free detection of FXYD3 using vial-based immunosensor for earlier and faster urothelial carcinoma diagnosis | |
CN107144688B (zh) | Cd19阳性外泌体作为分子标记在制备肿瘤诊断试剂盒中的应用及试剂盒 | |
Harris et al. | Affibodies as an alternative to antibodies in biosensors for cancer markers |